Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6

Coffee Break Life Sciences | Overview page

Navigating the revised EU Urban Wastewater Treatment Directive | Coffee Break Life Sciences #1

17 janvier 2025

par Dr. Kris Breudel, LL.M. (Aberdeen)

Regulatory Peculiarities |Coffee Break Life Sciences Start Ups #12

20 décembre 2024

Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11

19 novembre 2024

Think big – possible exit strategies | Coffee Break Life Sciences Start-ups #10

20 octobre 2024

par Alisa Mathes-Salathe

Data Protection for Life Sciences start-ups, particularly in connection with clinical trials | Coffee Break Life Sciences Start-ups #9

27 septembre 2024

par Dr. Tim Schwarz, Phillip Heske

Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8

22 août 2024

Clinical trials in the pharmaceutical area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #7

18 juillet 2024

par Irina Rebin

Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6

26 juin 2024

Employment Law in a Nutshell | Coffee Break Life Sciences Start-ups #5

15 mai 2024

par Dr. Jan W. Grawe

R&D Collaborations | Coffee Break Life Sciences Start-ups #4

18 avril 2024

par Irina Rebin

Tips and tricks for your financing round | Coffee Break Life Sciences Start-ups #3

20 mars 2024

par Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2

23 février 2024

Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1

30 janvier 2024